APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oncology API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchOncology API Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology API Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oncology API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology API Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology API Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Oncology API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology API include Fresenius Kabi Oncology, Suanfarma, Sterling, Shivalik Rasayan, PROCOS SPA, PolyPeptide, Olon Group, Neopharma and Natco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oncology API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncology API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncology API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oncology API market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncology API Segment by Company

Fresenius Kabi Oncology

Suanfarma

Sterling

Shivalik Rasayan

PROCOS SPA

PolyPeptide

Olon Group

Neopharma

Natco

Kekule Pharma

Hetero

GLS Pharma

Glenmark Life Sciences

Eisai Pharmaceuticals

Dr. Reddy's

CordenPharma

Concord Biotech

Biocon

Bachem

Aspen API

Aenova

Oncology API Segment by Type

Alkylating Agents

Antimetabolites

Others

Oncology API Segment by Application

Immunotherapy

Chemotherapy

Targeted Therapy

Others

Oncology API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncology API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oncology API Industry Trends Table 2. Oncology API Industry Drivers Table 3. Oncology API Industry Opportunities and Challenges Table 4. Oncology API Industry Restraints Table 5. Global Oncology API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oncology API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oncology API Sales by Manufacturers (K G) & (2021-2026) Table 8. Global Oncology API Sales Market Share by Manufacturers Table 9. Global Oncology API Average Sales Price (US$/G) of Manufacturers (2021-2026) Table 10. Global Oncology API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oncology API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oncology API Manufacturers, Product Type & Application Table 13. Global Oncology API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oncology API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Alkylating Agents Table 17. Major Manufacturers of Antimetabolites Table 18. Major Manufacturers of Others Table 19. Global Oncology API Sales by Type 2021 VS 2025 VS 2032 (K G) Table 20. Global Oncology API Sales by Type (2021-2026) & (K G) Table 21. Global Oncology API Sales by Type (2027-2032) & (K G) Table 22. Global Oncology API Sales Market Share by Type (2021-2026) Table 23. Global Oncology API Sales Market Share by Type (2027-2032) Table 24. Global Oncology API Revenue by Type 2021 VS 2025 VS 2032 (K G) Table 25. Global Oncology API Revenue by Type (2021-2026) & (K G) Table 26. Global Oncology API Revenue by Type (2027-2032) & (K G) Table 27. Global Oncology API Revenue Market Share by Type (2021-2026) Table 28. Global Oncology API Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Immunotherapy Table 30. Major Manufacturers of Chemotherapy Table 31. Major Manufacturers of Targeted Therapy Table 32. Major Manufacturers of Others Table 33. Global Oncology API Sales by Application 2021 VS 2025 VS 2032 (K G) Table 34. Global Oncology API Sales by Application (2021-2026) & (K G) Table 35. Global Oncology API Sales by Application (2027-2032) & (K G) Table 36. Global Oncology API Sales Market Share by Application (2021-2026) Table 37. Global Oncology API Sales Market Share by Application (2027-2032) Table 38. Global Oncology API Revenue by Application 2021 VS 2025 VS 2032 (K G) Table 39. Global Oncology API Revenue by Application (2021-2026) & (K G) Table 40. Global Oncology API Revenue by Application (2027-2032) & (K G) Table 41. Global Oncology API Revenue Market Share by Application (2021-2026) Table 42. Global Oncology API Revenue Market Share by Application (2027-2032) Table 43. Global Oncology API Sales by Region: 2021 VS 2025 VS 2032 (K G) Table 44. Global Oncology API Sales by Region (2021-2026) & (K G) Table 45. Global Oncology API Sales Market Share by Region (2021-2026) Table 46. Global Oncology API Sales Forecasted by Region (2027-2032) & (K G) Table 47. Global Oncology API Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 49. North America Oncology API Sales by Country (2021-2026) & (K G) Table 50. North America Oncology API Sales by Country (2027-2032) & (K G) Table 51. Europe Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 52. Europe Oncology API Sales by Country (2021-2026) & (K G) Table 53. Europe Oncology API Sales by Country (2027-2032) & (K G) Table 54. Asia Pacific Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 55. Asia Pacific Oncology API Sales by Country (2021-2026) & (K G) Table 56. Asia Pacific Oncology API Sales by Country (2027-2032) & (K G) Table 57. South America, Middle East and Africa Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 58. South America, Middle East and Africa Oncology API Sales by Country (2021-2026) & (K G) Table 59. South America, Middle East and Africa Oncology API Sales by Country (2027-2032) & (K G) Table 60. Global Oncology API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Oncology API Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Oncology API Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Oncology API Revenue Market Share by Region (2021-2026) Table 64. Global Oncology API Revenue Market Share by Region (2027-2032) Table 65. Fresenius Kabi Oncology Company Information Table 66. Fresenius Kabi Oncology Business Overview Table 67. Fresenius Kabi Oncology Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Fresenius Kabi Oncology Oncology API Product Portfolio Table 69. Fresenius Kabi Oncology Recent Development Table 70. Suanfarma Company Information Table 71. Suanfarma Business Overview Table 72. Suanfarma Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Suanfarma Oncology API Product Portfolio Table 74. Suanfarma Recent Development Table 75. Sterling Company Information Table 76. Sterling Business Overview Table 77. Sterling Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sterling Oncology API Product Portfolio Table 79. Sterling Recent Development Table 80. Shivalik Rasayan Company Information Table 81. Shivalik Rasayan Business Overview Table 82. Shivalik Rasayan Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Shivalik Rasayan Oncology API Product Portfolio Table 84. Shivalik Rasayan Recent Development Table 85. PROCOS SPA Company Information Table 86. PROCOS SPA Business Overview Table 87. PROCOS SPA Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. PROCOS SPA Oncology API Product Portfolio Table 89. PROCOS SPA Recent Development Table 90. PolyPeptide Company Information Table 91. PolyPeptide Business Overview Table 92. PolyPeptide Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. PolyPeptide Oncology API Product Portfolio Table 94. PolyPeptide Recent Development Table 95. Olon Group Company Information Table 96. Olon Group Business Overview Table 97. Olon Group Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Olon Group Oncology API Product Portfolio Table 99. Olon Group Recent Development Table 100. Neopharma Company Information Table 101. Neopharma Business Overview Table 102. Neopharma Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Neopharma Oncology API Product Portfolio Table 104. Neopharma Recent Development Table 105. Natco Company Information Table 106. Natco Business Overview Table 107. Natco Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Natco Oncology API Product Portfolio Table 109. Natco Recent Development Table 110. Kekule Pharma Company Information Table 111. Kekule Pharma Business Overview Table 112. Kekule Pharma Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Kekule Pharma Oncology API Product Portfolio Table 114. Kekule Pharma Recent Development Table 115. Hetero Company Information Table 116. Hetero Business Overview Table 117. Hetero Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hetero Oncology API Product Portfolio Table 119. Hetero Recent Development Table 120. GLS Pharma Company Information Table 121. GLS Pharma Business Overview Table 122. GLS Pharma Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. GLS Pharma Oncology API Product Portfolio Table 124. GLS Pharma Recent Development Table 125. Glenmark Life Sciences Company Information Table 126. Glenmark Life Sciences Business Overview Table 127. Glenmark Life Sciences Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Glenmark Life Sciences Oncology API Product Portfolio Table 129. Glenmark Life Sciences Recent Development Table 130. Eisai Pharmaceuticals Company Information Table 131. Eisai Pharmaceuticals Business Overview Table 132. Eisai Pharmaceuticals Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Eisai Pharmaceuticals Oncology API Product Portfolio Table 134. Eisai Pharmaceuticals Recent Development Table 135. Dr. Reddy's Company Information Table 136. Dr. Reddy's Business Overview Table 137. Dr. Reddy's Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Dr. Reddy's Oncology API Product Portfolio Table 139. Dr. Reddy's Recent Development Table 140. CordenPharma Company Information Table 141. CordenPharma Business Overview Table 142. CordenPharma Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. CordenPharma Oncology API Product Portfolio Table 144. CordenPharma Recent Development Table 145. Concord Biotech Company Information Table 146. Concord Biotech Business Overview Table 147. Concord Biotech Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Concord Biotech Oncology API Product Portfolio Table 149. Concord Biotech Recent Development Table 150. Biocon Company Information Table 151. Biocon Business Overview Table 152. Biocon Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Biocon Oncology API Product Portfolio Table 154. Biocon Recent Development Table 155. Bachem Company Information Table 156. Bachem Business Overview Table 157. Bachem Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Bachem Oncology API Product Portfolio Table 159. Bachem Recent Development Table 160. Aspen API Company Information Table 161. Aspen API Business Overview Table 162. Aspen API Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Aspen API Oncology API Product Portfolio Table 164. Aspen API Recent Development Table 165. Aenova Company Information Table 166. Aenova Business Overview Table 167. Aenova Oncology API Sales (K G), Price (US$/G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Aenova Oncology API Product Portfolio Table 169. Aenova Recent Development Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Oncology API Distributors List Table 173. Oncology API Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Oncology API Product Image Figure 2. Global Oncology API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology API Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology API Sales (2021-2032) & (K G) Figure 5. Global Oncology API Average Price (US$/G) & (2021-2032) Figure 6. Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Alkylating Agents Image Figure 9. Antimetabolites Image Figure 10. Others Image Figure 11. Global Oncology API Sales by Type (2021 VS 2025 VS 2032) & (K G) Figure 12. Global Oncology API Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oncology API Sales Market Share by Type (2021-2032) Figure 14. Global Oncology API Revenue by Type (2021 VS 2025 VS 2032) & (K G) Figure 15. Global Oncology API Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oncology API Revenue Market Share by Type (2021-2032) Figure 17. Immunotherapy Image Figure 18. Chemotherapy Image Figure 19. Targeted Therapy Image Figure 20. Others Image Figure 21. Global Oncology API Sales by Application (2021 VS 2025 VS 2032) & (K G) Figure 22. Global Oncology API Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oncology API Sales Market Share by Application (2021-2032) Figure 24. Global Oncology API Revenue by Application (2021 VS 2025 VS 2032) & (K G) Figure 25. Global Oncology API Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oncology API Revenue Market Share by Application (2021-2032) Figure 27. North America Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 28. North America Oncology API Sales Market Share by Country (2021-2032) Figure 29. U.S. Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 30. Canada Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 31. Mexico Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 32. Europe Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 33. Europe Oncology API Sales Market Share by Country (2021-2032) Figure 34. Germany Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 35. France Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 36. U.K. Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 37. Italy Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 38. Netherlands Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 39. Asia Pacific Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 40. Asia Pacific Oncology API Sales Market Share by Country (2021-2032) Figure 41. China Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 42. Japan Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 43. South Korea Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 44. Southeast Asia Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 45. India Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 46. Australia Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 47. South America, Middle East and Africa Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 48. South America, Middle East and Africa Oncology API Sales Market Share by Country (2021-2032) Figure 49. Brazil Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 50. South Africa Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 51. Saudi Arabia Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 52. Turkey Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 53. Argentina Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 54. UAE Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 55. Egypt Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 56. Chile Oncology API Sales and Growth Rate (2021-2032) & (K G) Figure 57. Global Oncology API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Oncology API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Oncology API Revenue (2021-2032) & (US$ Million) Figure 60. North America Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Oncology API Revenue (2021-2032) & (US$ Million) Figure 62. Europe Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Oncology API Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Oncology API Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Oncology API Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Oncology API Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Alkylating Agents
  • Antimetabolites
  • Others
Applications
  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Companies covered
  • Fresenius Kabi Oncology
  • Suanfarma
  • Sterling
  • Shivalik Rasayan
  • PROCOS SPA
  • PolyPeptide
  • Olon Group
  • Neopharma
  • Natco
  • Kekule Pharma
  • Hetero
  • GLS Pharma
  • Glenmark Life Sciences
  • Eisai Pharmaceuticals
  • Dr. Reddy's
  • CordenPharma
  • Concord Biotech
  • Biocon
  • Bachem
  • Aspen API
  • Aenova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oncology API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oncology API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oncology API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oncology API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oncology API Market Dynamics
  1. 2.1 Oncology API Industry Trends
  2. 2.2 Oncology API Industry Drivers
  3. 2.3 Oncology API Industry Opportunities and Challenges
  4. 2.4 Oncology API Industry Restraints
3 Oncology API Market by Manufacturers
  1. 3.1 Global Oncology API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oncology API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oncology API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oncology API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oncology API Manufacturers, Product Type & Application
  7. 3.7 Global Oncology API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology API Tier 1, Tier 2, and Tier 3
4 Oncology API Market by Type
  1. 4.1 Oncology API Type Introduction
  2. 4.1.1 Alkylating Agents
  3. 4.1.2 Antimetabolites
  4. 4.1.3 Others
  5. 4.2 Global Oncology API Sales by Type
  6. 4.2.1 Global Oncology API Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oncology API Sales by Type (2021-2032)
  8. 4.2.3 Global Oncology API Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oncology API Revenue by Type
  10. 4.3.1 Global Oncology API Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oncology API Revenue by Type (2021-2032)
  12. 4.3.3 Global Oncology API Revenue Market Share by Type (2021-2032)
5 Oncology API Market by Application
  1. 5.1 Oncology API Application Introduction
  2. 5.1.1 Immunotherapy
  3. 5.1.2 Chemotherapy
  4. 5.1.3 Targeted Therapy
  5. 5.1.4 Others
  6. 5.2 Global Oncology API Sales by Application
  7. 5.2.1 Global Oncology API Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oncology API Sales by Application (2021-2032)
  9. 5.2.3 Global Oncology API Sales Market Share by Application (2021-2032)
  10. 5.3 Global Oncology API Revenue by Application
  11. 5.3.1 Global Oncology API Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oncology API Revenue by Application (2021-2032)
  13. 5.3.3 Global Oncology API Revenue Market Share by Application (2021-2032)
6 Global Oncology API Sales by Region
  1. 6.1 Global Oncology API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oncology API Sales by Region (2021-2032)
  3. 6.2.1 Global Oncology API Sales by Region (2021-2026)
  4. 6.2.2 Global Oncology API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oncology API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oncology API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oncology API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oncology API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oncology API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oncology API Revenue by Region
  1. 7.1 Global Oncology API Revenue by Region
  2. 7.1.1 Global Oncology API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oncology API Revenue by Region (2021-2026)
  4. 7.1.3 Global Oncology API Revenue by Region (2027-2032)
  5. 7.1.4 Global Oncology API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oncology API Revenue (2021-2032)
  8. 7.2.2 North America Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oncology API Revenue (2021-2032)
  11. 7.3.2 Europe Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oncology API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oncology API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oncology API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Fresenius Kabi Oncology
  2. 8.1.1 Fresenius Kabi Oncology Company Information
  3. 8.1.2 Fresenius Kabi Oncology Business Overview
  4. 8.1.3 Fresenius Kabi Oncology Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fresenius Kabi Oncology Oncology API Product Portfolio
  6. 8.1.5 Fresenius Kabi Oncology Recent Developments
  7. 8.2 Suanfarma
  8. 8.2.1 Suanfarma Company Information
  9. 8.2.2 Suanfarma Business Overview
  10. 8.2.3 Suanfarma Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Suanfarma Oncology API Product Portfolio
  12. 8.2.5 Suanfarma Recent Developments
  13. 8.3 Sterling
  14. 8.3.1 Sterling Company Information
  15. 8.3.2 Sterling Business Overview
  16. 8.3.3 Sterling Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sterling Oncology API Product Portfolio
  18. 8.3.5 Sterling Recent Developments
  19. 8.4 Shivalik Rasayan
  20. 8.4.1 Shivalik Rasayan Company Information
  21. 8.4.2 Shivalik Rasayan Business Overview
  22. 8.4.3 Shivalik Rasayan Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shivalik Rasayan Oncology API Product Portfolio
  24. 8.4.5 Shivalik Rasayan Recent Developments
  25. 8.5 PROCOS SPA
  26. 8.5.1 PROCOS SPA Company Information
  27. 8.5.2 PROCOS SPA Business Overview
  28. 8.5.3 PROCOS SPA Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PROCOS SPA Oncology API Product Portfolio
  30. 8.5.5 PROCOS SPA Recent Developments
  31. 8.6 PolyPeptide
  32. 8.6.1 PolyPeptide Company Information
  33. 8.6.2 PolyPeptide Business Overview
  34. 8.6.3 PolyPeptide Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PolyPeptide Oncology API Product Portfolio
  36. 8.6.5 PolyPeptide Recent Developments
  37. 8.7 Olon Group
  38. 8.7.1 Olon Group Company Information
  39. 8.7.2 Olon Group Business Overview
  40. 8.7.3 Olon Group Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Olon Group Oncology API Product Portfolio
  42. 8.7.5 Olon Group Recent Developments
  43. 8.8 Neopharma
  44. 8.8.1 Neopharma Company Information
  45. 8.8.2 Neopharma Business Overview
  46. 8.8.3 Neopharma Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Neopharma Oncology API Product Portfolio
  48. 8.8.5 Neopharma Recent Developments
  49. 8.9 Natco
  50. 8.9.1 Natco Company Information
  51. 8.9.2 Natco Business Overview
  52. 8.9.3 Natco Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Natco Oncology API Product Portfolio
  54. 8.9.5 Natco Recent Developments
  55. 8.10 Kekule Pharma
  56. 8.10.1 Kekule Pharma Company Information
  57. 8.10.2 Kekule Pharma Business Overview
  58. 8.10.3 Kekule Pharma Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kekule Pharma Oncology API Product Portfolio
  60. 8.10.5 Kekule Pharma Recent Developments
  61. 8.11 Hetero
  62. 8.11.1 Hetero Company Information
  63. 8.11.2 Hetero Business Overview
  64. 8.11.3 Hetero Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hetero Oncology API Product Portfolio
  66. 8.11.5 Hetero Recent Developments
  67. 8.12 GLS Pharma
  68. 8.12.1 GLS Pharma Company Information
  69. 8.12.2 GLS Pharma Business Overview
  70. 8.12.3 GLS Pharma Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GLS Pharma Oncology API Product Portfolio
  72. 8.12.5 GLS Pharma Recent Developments
  73. 8.13 Glenmark Life Sciences
  74. 8.13.1 Glenmark Life Sciences Company Information
  75. 8.13.2 Glenmark Life Sciences Business Overview
  76. 8.13.3 Glenmark Life Sciences Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Glenmark Life Sciences Oncology API Product Portfolio
  78. 8.13.5 Glenmark Life Sciences Recent Developments
  79. 8.14 Eisai Pharmaceuticals
  80. 8.14.1 Eisai Pharmaceuticals Company Information
  81. 8.14.2 Eisai Pharmaceuticals Business Overview
  82. 8.14.3 Eisai Pharmaceuticals Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eisai Pharmaceuticals Oncology API Product Portfolio
  84. 8.14.5 Eisai Pharmaceuticals Recent Developments
  85. 8.15 Dr. Reddy's
  86. 8.15.1 Dr. Reddy's Company Information
  87. 8.15.2 Dr. Reddy's Business Overview
  88. 8.15.3 Dr. Reddy's Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy's Oncology API Product Portfolio
  90. 8.15.5 Dr. Reddy's Recent Developments
  91. 8.16 CordenPharma
  92. 8.16.1 CordenPharma Company Information
  93. 8.16.2 CordenPharma Business Overview
  94. 8.16.3 CordenPharma Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CordenPharma Oncology API Product Portfolio
  96. 8.16.5 CordenPharma Recent Developments
  97. 8.17 Concord Biotech
  98. 8.17.1 Concord Biotech Company Information
  99. 8.17.2 Concord Biotech Business Overview
  100. 8.17.3 Concord Biotech Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Concord Biotech Oncology API Product Portfolio
  102. 8.17.5 Concord Biotech Recent Developments
  103. 8.18 Biocon
  104. 8.18.1 Biocon Company Information
  105. 8.18.2 Biocon Business Overview
  106. 8.18.3 Biocon Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Biocon Oncology API Product Portfolio
  108. 8.18.5 Biocon Recent Developments
  109. 8.19 Bachem
  110. 8.19.1 Bachem Company Information
  111. 8.19.2 Bachem Business Overview
  112. 8.19.3 Bachem Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bachem Oncology API Product Portfolio
  114. 8.19.5 Bachem Recent Developments
  115. 8.20 Aspen API
  116. 8.20.1 Aspen API Company Information
  117. 8.20.2 Aspen API Business Overview
  118. 8.20.3 Aspen API Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aspen API Oncology API Product Portfolio
  120. 8.20.5 Aspen API Recent Developments
  121. 8.21 Aenova
  122. 8.21.1 Aenova Company Information
  123. 8.21.2 Aenova Business Overview
  124. 8.21.3 Aenova Oncology API Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Aenova Oncology API Product Portfolio
  126. 8.21.5 Aenova Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oncology API Value Chain Analysis
  2. 9.1.1 Oncology API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oncology API Production Mode & Process
  6. 9.2 Oncology API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oncology API Distributors
  9. 9.2.3 Oncology API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst